Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

HB 4783 requires Texas state agencies and institutions of higher education distributing opioid overdose reversal medications (like naloxone) to prepare a biennial report every even-numbered year by October 1. The report must assess current distribution needs, establish statewide goals for medication availability, detail funding sources, outline distribution strategies, and recommend improvements for high-risk groups including rural communities, pregnant individuals, and children. It mandates coordination with all relevant agencies and requires submission of the report to the governor, lieutenant governor, and House speaker. The bill, now law after being signed by the governor on June 20, 2025, does not change current policies but creates a structured reporting requirement to inform future opioid overdose prevention efforts.